These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 1347599)

  • 1. Paf-acether in stool as marker of intestinal inflammation.
    Chaussade S; Denizot Y; Colombel JF; Benvensite J; Couturier D
    Lancet; 1992 Mar; 339(8795):739. PubMed ID: 1347599
    [No Abstract]   [Full Text] [Related]  

  • 2. Presence of PAF-acether in stool of patients with infectious diarrhea.
    Denizot Y; Chaussade S; Benveniste J; Couturier D
    J Infect Dis; 1991 May; 163(5):1168. PubMed ID: 2019768
    [No Abstract]   [Full Text] [Related]  

  • 3. [Presence paf-acether mediator of inflammation in stools of patients with inflammatory enterocolitis].
    Denizot Y; Chaussade S; Colombel JF; Benveniste J; Couturier D
    C R Acad Sci III; 1991; 312(7):329-33. PubMed ID: 1908742
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Platelet activating factor in stool from patients with ulcerative colitis and Crohn's disease.
    Hocke M; Richter L; Bosseckert H; Eitner K
    Hepatogastroenterology; 1999; 46(28):2333-7. PubMed ID: 10521992
    [TBL] [Abstract][Full Text] [Related]  

  • 5. PAF-acether and acetylhydrolase in stool of patients with Crohn's disease.
    Denizot Y; Chaussade S; Nathan N; Colombel JF; Bossant MJ; Cherouki N; Benveniste J; Couturier D
    Dig Dis Sci; 1992 Mar; 37(3):432-7. PubMed ID: 1735366
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Contamination of fermented milk products by proinflammatory autacoid paf-acether].
    Denizot Y; Benveniste J
    C R Acad Sci III; 1989; 309(14):593-7. PubMed ID: 2510911
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Novel aspect of Crohn's disease: increased content of platelet-activating factor in ileal and colonic mucosa.
    Kald B; Olaison G; Sjödahl R; Tagesson C
    Digestion; 1990; 46(4):199-204. PubMed ID: 2282995
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Assessment of fecal calprotectin concentration as inflammatory marker in inflammatory bowel diseases in children--preliminary report].
    Krzesiek E; Iwańczak B
    Pol Merkur Lekarski; 2010 Oct; 29(172):241-6. PubMed ID: 21207640
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Platelet-activating factor (PAF-acether) formation in neonatal intestinal mucosa and in cultured intestinal epithelial cells.
    Kald B; Gustafson C; Franzén L; Weström B; Sjödahl R; Tagesson C
    Eur Surg Res; 1992; 24(6):325-32. PubMed ID: 1292936
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Biochemical and pharmacological characterization of human embryo-derived platelet activating factor.
    Collier M; O'Neill C; Ammit AJ; Saunders DM
    Hum Reprod; 1988 Nov; 3(8):993-8. PubMed ID: 3204154
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Study of platelet-activating factor (PAF) in stools of newborn infants with hemorrhagic colitis].
    de Boissieu D; Badoual J; Dupont C; Chaussade S; Denizot Y; Benveniste J
    Arch Fr Pediatr; 1991; 48(7):515-6. PubMed ID: 1929756
    [No Abstract]   [Full Text] [Related]  

  • 12. Inflammatory actions of platelet activating factor (Pafacether) in guinea-pig skin.
    Morley J; Page CP; Paul W
    Br J Pharmacol; 1983 Nov; 80(3):503-9. PubMed ID: 6685552
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tumor necrosis factor and platelet activating factor in stool during salmonellosis.
    Denizot Y; Chaussade S
    Gut; 1994 Feb; 35(2):287. PubMed ID: 8307492
    [No Abstract]   [Full Text] [Related]  

  • 14. Fecal calprotectin as a promising marker of inflammatory diseases.
    Paduchova Z; Durackova Z
    Bratisl Lek Listy; 2009; 110(10):598-602. PubMed ID: 20017448
    [TBL] [Abstract][Full Text] [Related]  

  • 15. PAF-acether (PAF) in Ehrlich ascites tumour cells.
    Marathe GK; Krishnakanta TP; D'Souza CJ
    J Lipid Mediat; 1990; 2(5):257-62. PubMed ID: 2133270
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cooperation between platelets and neutrophils for paf-acether (platelet-activating factor) formation.
    Coëffier E; Delautier D; Le Couedic JP; Chignard M; Denizot Y; Benveniste J
    J Leukoc Biol; 1990 Mar; 47(3):234-43. PubMed ID: 2307906
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inflammatory characteristics of PAF-acether in the skin of experimental animals and man.
    Archer CB; Page CP; Paul W; Morley J; MacDonald DM
    Int J Tissue React; 1985; 7(5):363-5. PubMed ID: 3863807
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Synthesis of paf-acether by E. coli K12].
    Thomas Y; Denizot Y; Dassa E; Boullet C; Benveniste J
    C R Acad Sci III; 1986; 303(17):699-702. PubMed ID: 3101984
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The physiopathology of acute pancreatitis: the role of platelet-activating factor (PAF)].
    Ais JG; Novo C; Gómez-Garre M; López-Farre A; López-Novoa JM; Romeo JM
    Rev Esp Enferm Dig; 1992 Jan; 81(1):25-8. PubMed ID: 1547030
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Fecal platelet-activating factor (PAF). A marker of digestive inflammatory disorders].
    Denizot Y; Chaussade S; Couturier D
    Presse Med; 1993 Oct; 22(33):1704-6. PubMed ID: 8278326
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.